{
    "2019-04-12": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Novo Nordisk",
                        "Trials",
                        "Liver Disease",
                        "Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Novo Nordisk and Gilead team up to test fatty liver disease treatment",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Gilead",
                        "fatty liver disease",
                        "treatment"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}